Valtensam Comp 5 mg/160 mg/25 mg Filmdragerad tablett

البلد: السويد

اللغة: السويدية

المصدر: Läkemedelsverket (Medical Products Agency)

اشتر الآن

خصائص المنتج خصائص المنتج (SPC)
16-04-2020

العنصر النشط:

amlodipinbesilat; hydroklortiazid; valsartan

متاح من:

Teva B.V.

ATC رمز:

C09DX01

INN (الاسم الدولي):

amlodipinbesilat; hydrochlorothiazide; valsartan

جرعة:

5 mg/160 mg/25 mg

الشكل الصيدلاني:

Filmdragerad tablett

تركيب:

valsartan 160 mg Aktiv substans; amlodipinbesilat 6,93 mg Aktiv substans; hydroklortiazid 25 mg Aktiv substans; laktosmonohydrat Hjälpämne

نوع الوصفة الطبية :

Receptbelagt

ملخص المنتج:

Förpacknings: Blister, 14 tabletter; Blister, 28 tabletter; Blister, 30 tabletter; Blister, 56 tabletter; Blister, 90 tabletter; Blister, 98 tabletter; Burk, 100 tabletter

الوضع إذن:

Avregistrerad

تاريخ الترخيص:

2020-04-15

خصائص المنتج

                                1
SUMMARY OF PRODUCT CHARACTERISTICS
1.
NAME OF THE MEDICINAL PRODUCT
Valtensam Comp 10 mg/160 mg/12.5 mg film-coated tablets
Valtensam Comp 5 mg/160 mg/25 mg film-coated tablets
Valtensam Comp 10 mg/160 mg/25 mg film-coated tablets
2.
QUALITATIVE AND QUANTITATIVE COMPOSITION
[Product name] 10 mg/160 mg/12.5 mg film-coated tablets
Each film-coated tablet contains amlodipine besilate equivalent to 10
mg amlodipine, 160 mg of
valsartan, and 12.5 mg of hydrochlorothiazide.
[Product name] 5 mg/160 mg/25 mg film-coated tablets
Each film-coated tablet containsamlodipine besilate equivalent to 5 mg
amlodipine, 160 mg of
valsartan, and 25 mg of hydrochlorothiazide.
[Product name] 10 mg/160 mg/25 mg film-coated tablets
Each film-coated tablet containsamlodipine besilate equivalent to 10
mg amlodipine, 160 mg of
valsartan, and 25 mg of hydrochlorothiazide.
Excipient(s) with known effect
[Product name] 10 mg/160 mg/12.5 mg film-coated tablets
Each tablet contains 5 mg of lactose.
[Product name] 5 mg/160 mg/25 mg film-coated tablets
Each tablet contains 5 mg of lactose.
[Product name] 10 mg/160 mg/25 mg film-coated tablets
Each tablet contains 5 mg of lactose.
For the full list of excipients, see section 6.1.
3.
PHARMACEUTICAL FORM
Film-coated tablet (tablet)
[Product name] 10 mg/160 mg/12.5 mg film-coated tablets
Oval, light yellow, 14.5 mm x 7.5 mm film-coated tablets with bevelled
edges, with debossing VIL on
one side of the tablet.
[Product name] 5 mg/160 mg/25 mg film-coated tablets
Oval, yellow, 14.5 mm x 7.5 mm film-coated tablets with bevelled
edges, with debossing VIH on one
side of the tablet
[Product name] 10 mg/160 mg/25 mg film-coated tablets
Oval, dark yellow, 14.5 mm x 7.5 mm film-coated tablets with bevelled
edges, with debossing VIT on
one side of the tablet.
2
4.
CLINICAL PARTICULARS
4.1
THERAPEUTIC INDICATIONS
Treatment of essential hypertension as substitution therapy in adult
patients whose blood pressure is
adequately controlled on the combination of amlodipine, valsartan and
hydrochlorothiazide (HCT),

                                
                                اقرأ الوثيقة كاملة
                                
                            

مستندات بلغات أخرى

نشرة المعلومات نشرة المعلومات الإنجليزية 12-08-2022
خصائص المنتج خصائص المنتج الإنجليزية 12-08-2022
تقرير التقييم الجمهور تقرير التقييم الجمهور الإنجليزية 27-05-2020